Mapping the patent landscape of medical machine learning
Artificial intelligence is rapidly entering the field of medicine, but the role of patents in this process remains relatively opaque. Regulators report hundreds of machine learning medical devices that have passed regulatory oversight, including systems involved in radiology, cardiology, ophthalmology and many other fields.
Major hospitals and academic medical systems have both developed and deployed AI and ML systems, and some AI tools have been embedded in electronic health records used by health systems covering millions of patients. Nevertheless, despite this wave of innovation in medical machine learning , the influence of patents on that process has only been sketched rather than interrogated in detail.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nature Biotechnology - Fluorescence microscopyArtistic rendering of nucleosomes labeled with a reversibly switchable green fluorescent protein and portrayed as spinning tops on a plate. Volpato et al....
Read more »
Genetically encoded barcodes for correlative volume electron microscopy - Nature BiotechnologyMultiplexable barcodes for electron microscopy are applied to brain imaging.
Read more »
Integrating a healthcare innovation bootcamp into an international medical conference to democratize innovation learning - Nature BiotechnologyIntegration of an intensive innovation education bootcamp into a large international conference demonstrates statistically significant increases in participant understanding and knowledge of healthcare innovation.
Read more »
Giant exoplanet found, imaged directly thanks to star-mapping data (photos)The approach could lead to many more exoplanets being directly detected and imaged.
Read more »
CEO shares the simple exercise that helped her land her dream job: ‘You need to be vocal about what you want’Essence CEO Carolina Wanga reveals her best tips for mapping out your dream career.
Read more »
US Supreme Court rebuffs Novartis bid to revive MS drug Gilenya patentThe U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp's bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China's HEC Pharm Co Ltd .
Read more »